Yong-Bok Lee at College of Pharmacy - Research Interests, Publications & Academic Profile | ApplyKite India

Yong-Bok Lee

University Name

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

.

ORCID

.

LinkedIn

Social connections

How do Indian students reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI

Contact this professor

LinkedIn

Google Scholar

Research Interests

Pharmacology

100%

Pharmacotherapy

100%

Pharmacokinetic

100%

Drug Utilization

50%

Cytochrome P450

50%

Toxicology

40%

Dose Optimization

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Is Gender an Important Factor in the Precision Medicine Approach to Levocetirizine?

Year:

2024

Sex differences in 4-tert-octylphenol toxicokinetics: Exploration of sex as an effective covariate through an in vivo modeling approach

Year:

2024

Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling

Year:

2023

Inter-individual exposure variability interpretation through reflection of biological age algorithm in physiologically based toxicokinetic model: Application to human risk assessment of di-isobutyl-phthalate

Year:

2023

Establishment of a fexofenadine population pharmacokinetic (PK)–pharmacodynamic (PD) model and exploration of dosing regimens through simulation

Year:

2023

Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model

Year:

2023

Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen

Year:

2023

Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors

Year:

2023

A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function

Year:

2023

Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite

Year:

2023

Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms

Year:

2022

Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Year:

2022

Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics

Year:

2022

Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with Cirrhosis

Year:

2022

Human risk assessment of 4-n-nonylphenol (4-n-NP) using physiologically based pharmacokinetic (PBPK) modeling: analysis of gender exposure differences and application to exposure analysis related to large exposure variability in population

Year:

2022

Collaborators1

Hea-Young Cho

Associate Professor

CHA University

SOUTH KOREA

Social connections

How do Indian students reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI